Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,174,510
+$26,085,700 QoQ
Shares Held
323,245
-15.2% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 415 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 4%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Derivatives in LGND
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$5,183,298
PutShares
54,502
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. LGND ranks #35 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in LGND
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,174,510 | 323,245 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $76,088,810 | 381,111 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $81,111,785 | 429,004 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $65,151,205 | 367,795 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,243,916 | 63,722 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,921,654 | 84,855 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $11,851,753 | 110,609 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,533,871 | 95,253 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,442,942 | 64,597 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,174,814 | 57,111 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,562,023 | 63,876 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,184,872 | 69,841 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $7,699,846 | 106,794 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $4,560,057 | 61,991 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,124,565 | 61,745 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,079,119 | 35,758 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $3,885,170 | 43,546 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $6,058,600 | 53,859 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,573,322 | 87,876 | Shares | Defined | 2022-02-17 | |
| 2021-06-30 | $12,835,104 | 97,836 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,183,298 | 34,000 | Put | Defined | 2021-05-17 | |
| 2021-03-31 | $20,408,626 | 133,871 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $15,862,268 | 159,500 | Put | Defined | 2021-02-12 | |
| 2020-12-31 | $26,720,811 | 268,686 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $27,871,565 | 292,400 | Put | Defined | 2020-11-13 | |
| 2020-09-30 | $3,812,799 | 40,000 | Call | Defined | 2020-11-13 | |
| 2020-09-30 | $9,868,859 | 103,534 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,324,058 | 47,600 | Call | Defined | 2020-08-12 | |
| 2020-06-30 | $12,641,842 | 113,025 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $29,729,721 | 265,800 | Put | Defined | 2020-08-12 | |
| 2020-03-31 | $5,773,962 | 79,400 | Put | Defined | 2020-05-15 | |
| 2020-03-31 | $8,535,865 | 117,380 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||